Transplant Diagnostics Market
Transplant Diagnostics Market Forecasts to 2032 – Global Analysis By Test Type (Molecular Assays, Non-Molecular Assays, and Sequencing-based Molecular Assays), Biomarker Type, Transplant Type, Application, End User and By Geography
According to Stratistics MRC, the Global Transplant Diagnostics Market is accounted for $6.99 billion in 2025 and is expected to reach $13.11 billion by 2032 growing at a CAGR of 9.4% during the forecast period. Transplant diagnostics is a medical discipline focused on examining and monitoring the health and compatibility of transplanted organs or tissues. It encompasses testing to ensure donor-recipient matching, tracking organ functionality, and identifying potential rejection or infections at an early stage. Through precise and prompt assessments, this field assists healthcare providers in enhancing patient outcomes, prolonging graft longevity, and minimizing complications.
According to the Health Resources & Services Administration (HRSA), as of March 2024, more than 46,000 organ transplants were performed in the U.S.
Market Dynamics:
Driver:
Rising prevalence of chronic diseases
Healthcare providers are seeking precise testing methods to optimize donor-recipient matching and improve patient outcomes. Innovations in molecular and immunological assays are allowing earlier detection of transplant complications. Aging populations and rising comorbidity rates are expanding the need for diagnostic monitoring post-transplant. Hospitals and specialized clinics are adopting cutting-edge diagnostic platforms to reduce rejection risks. The growth of personalized medicine is encouraging the use of tailored diagnostic panels for each patient. Overall, the surge in chronic disease prevalence is accelerating the adoption of sophisticated transplant diagnostic solutions.
Restraint:
Organ shortage gap
Limited organ availability increases the pressure on diagnostic workflows to maximize graft success. Regulatory hurdles and strict ethical guidelines further complicate donor matching processes. Small laboratories and emerging market facilities often face resource constraints that restrict adoption of advanced tests. Prolonged approval timelines for new diagnostic kits delay clinical implementation. These limitations may hinder investment in innovative technologies despite clinical need. As a result, the organ supply-demand gap continues to restrain the expansion of the transplant diagnostics market.
Opportunity:
AI and machine learning
Predictive algorithms can enhance donor-recipient compatibility assessments and forecast graft survival. Automated data analysis reduces diagnostic errors and accelerates decision-making in transplant centers. Machine learning models are increasingly applied to interpret complex immunological and genomic datasets. Adoption of AI-driven platforms allows laboratories to improve efficiency while reducing operational costs. Cloud-based analytics facilitate real-time monitoring of transplant patients across multiple facilities. This trend is expected to transform transplant diagnostics by enabling precision medicine and predictive care solutions.
Threat:
Ethical & data privacy concerns
The handling of sensitive genomic and immunological information requires strict compliance with data protection regulations. Misuse or breaches of health data could erode trust in diagnostic services. Ethical debates around donor consent and organ allocation may affect market acceptance. Regulatory differences across regions create complexities for multinational diagnostic providers. Ensuring secure data storage and adherence to privacy standards increases operational costs. These concerns could slow the adoption of advanced transplant diagnostic technologies in some markets.
Covid-19 Impact:
Laboratory operations faced temporary closures and staffing shortages, affecting sample processing. Global supply chains for diagnostic reagents and kits experienced interruptions, limiting test availability. Telemedicine and remote monitoring were rapidly adopted to maintain patient follow-up and post-transplant care. Regulatory authorities introduced expedited approvals for critical diagnostic tools to support urgent cases. The crisis highlighted the need for resilient supply chains and decentralized laboratory networks. Post-pandemic, transplant diagnostics are focusing on automation, rapid testing, and operational flexibility to prevent future disruptions.
The molecular assays segment is expected to be the largest during the forecast period
The molecular assays segment is expected to account for the largest market share during the forecast period, due to their high sensitivity and specificity in detecting transplant-related complications. These assays are widely used for monitoring viral infections, graft rejection, and immune response. Technological advancements, such as multiplex PCR and next-generation sequencing, are expanding their clinical utility. Laboratories are increasingly implementing molecular platforms for faster turnaround times. Adoption is driven by growing awareness of early intervention benefits for transplant patients.
The reference labs segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the reference labs segment is predicted to witness the highest growth rate, due to their capacity for high-throughput and specialized testing. These facilities provide advanced diagnostic services that smaller hospitals may lack. Investments in automated platforms and AI-assisted interpretation improve efficiency and accuracy. Outsourcing diagnostic testing to reference labs reduces operational burdens for transplant centers. Rising demand for complex immunological and genomic testing is driving expansion. Reference labs are also expanding their global footprint to cater to emerging markets.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, due to its advanced healthcare infrastructure and strong adoption of innovative diagnostics. The U.S. and Canada have well-established transplant networks and specialized laboratories. High awareness of organ rejection risks is driving demand for sophisticated testing. Investment in R&D and regulatory support encourage development and commercialization of new assays. Strategic collaborations between academic centers and diagnostic companies are common. The region benefits from robust reimbursement frameworks that facilitate widespread diagnostic adoption.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by expanding healthcare infrastructure and increasing organ transplant programs. Countries like China, India, and Japan are investing heavily in modern laboratories and diagnostic technologies. Growing incidence of chronic diseases and rising awareness of transplant monitoring is boosting demand. Government initiatives are supporting local manufacturing and technology transfer. International collaborations are enabling access to advanced molecular and immunological assays. Rapid adoption of AI-enabled diagnostic platforms is enhancing testing accuracy.
Key players in the market
Some of the key players in Transplant Diagnostics Market include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Illumina, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Immucor, Inc., CareDx, Inc., Omixon Inc., Hologic, Inc., Adaptive Biotechnologies Corporation, NanoString Technologies, Inc., Eurofins Viracor, and GenDx.
Key Developments:
In January 2026, Thermo Fisher Scientific Inc. announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The effort will leverage the NVIDIA Artificial Intelligence (AI) platform and Thermo Fisher Scientific solutions to progressively increase the automation, accuracy and speed of laboratories. The companies are working together to evolve the digital foundation that powers scientific instruments, laboratory infrastructure and data.
In January 2026, Abbott announced a collaboration with AtaCor Medical to advance a next-generation investigational extravascular implantable cardioverter defibrillator (EV-ICD) system designed to deliver defibrillation therapy to people with life-threatening heart rhythms. Through the collaboration, AtaCor's investigational parasternal EV-ICD lead (Atala™) will be paired with Abbott's investigational ICD system.
Test Types Covered:
• Molecular Assays
• Non-Molecular Assays
• Sequencing-based Molecular Assays
Biomarker Types Covered:
• Instruments
• Genomic Biomarkers
• Proteomic Biomarkers
• Cellular Biomarkers
• Metabolomic Biomarkers
Transplant Types Covered:
• Kidney Transplant
• Liver Transplant
• Heart Transplant
• Lung Transplant
• Bone Marrow Transplant
• Other Organ Transplants
Applications Covered:
• Human Leukocyte Antigen (HLA) Testing
• Blood Profile Testing
• Pathogen Detection
• Crossmatching
• Other Applications
End Users Covered:
• Hospitals & Clinics
• Diagnostic Laboratories
• Research & Academic Institutes
• Reference Labs
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Transplant Diagnostics Market, By Test Type
5.1 Introduction
5.2 Molecular Assays
5.2.1 PCR-based assays
5.2.2 Real-time PCR
5.2.3 Next-Generation Sequencing (NGS)
5.2.4 Sanger Sequencing
5.3 Non-Molecular Assays
5.3.1 Serological Assays
5.3.2 Mixed Lymphocyte Culture
5.4 Sequencing-based Molecular Assays
6 Global Transplant Diagnostics Market, By Biomarker Type
6.1 Introduction
6.2 Instruments
6.3 Genomic Biomarkers
6.4 Proteomic Biomarkers
6.5 Cellular Biomarkers
6.6 Metabolomic Biomarkers
7 Global Transplant Diagnostics Market, By Transplant Type
7.1 Introduction
7.2 Kidney Transplant
7.3 Liver Transplant
7.4 Heart Transplant
7.5 Lung Transplant
7.6 Bone Marrow Transplant
7.7 Other Organ Transplants
8 Global Transplant Diagnostics Market, By Application
8.1 Introduction
8.2 Human Leukocyte Antigen (HLA) Testing
8.3 Blood Profile Testing
8.4 Pathogen Detection
8.5 Crossmatching
8.6 Other Applications
9 Global Transplant Diagnostics Market, By End User
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Diagnostic Laboratories
9.4 Research & Academic Institutes
9.5 Reference Labs
9.6 Other End Users
10 Global Transplant Diagnostics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Thermo Fisher Scientific, Inc.
12.2 F. Hoffmann-La Roche Ltd.
12.3 Abbott Laboratories
12.4 Illumina, Inc.
12.5 QIAGEN N.V.
12.6 Bio-Rad Laboratories, Inc.
12.7 Becton, Dickinson and Company
12.8 Immucor, Inc.
12.9 CareDx, Inc.
12.10 Omixon Inc.
12.11 Hologic, Inc.
12.12 Adaptive Biotechnologies Corporation
12.13 NanoString Technologies, Inc.
12.14 Eurofins Viracor
12.15 GenDx
List of Tables
1 Global Transplant Diagnostics Market Outlook, By Region (2024-2032) ($MN)
2 Global Transplant Diagnostics Market Outlook, By Test Type (2024-2032) ($MN)
3 Global Transplant Diagnostics Market Outlook, By Molecular Assays (2024-2032) ($MN)
4 Global Transplant Diagnostics Market Outlook, By PCR-based assays (2024-2032) ($MN)
5 Global Transplant Diagnostics Market Outlook, By Real-time PCR (2024-2032) ($MN)
6 Global Transplant Diagnostics Market Outlook, By Next-Generation Sequencing (NGS) (2024-2032) ($MN)
7 Global Transplant Diagnostics Market Outlook, By Sanger Sequencing (2024-2032) ($MN)
8 Global Transplant Diagnostics Market Outlook, By Non-Molecular Assays (2024-2032) ($MN)
9 Global Transplant Diagnostics Market Outlook, By Serological Assays (2024-2032) ($MN)
10 Global Transplant Diagnostics Market Outlook, By Mixed Lymphocyte Culture (2024-2032) ($MN)
11 Global Transplant Diagnostics Market Outlook, By Sequencing-based Molecular Assays (2024-2032) ($MN)
12 Global Transplant Diagnostics Market Outlook, By Biomarker Type (2024-2032) ($MN)
13 Global Transplant Diagnostics Market Outlook, By Instruments (2024-2032) ($MN)
14 Global Transplant Diagnostics Market Outlook, By Genomic Biomarkers (2024-2032) ($MN)
15 Global Transplant Diagnostics Market Outlook, By Proteomic Biomarkers (2024-2032) ($MN)
16 Global Transplant Diagnostics Market Outlook, By Cellular Biomarkers (2024-2032) ($MN)
17 Global Transplant Diagnostics Market Outlook, By Metabolomic Biomarkers (2024-2032) ($MN)
18 Global Transplant Diagnostics Market Outlook, By Transplant Type (2024-2032) ($MN)
19 Global Transplant Diagnostics Market Outlook, By Kidney Transplant (2024-2032) ($MN)
20 Global Transplant Diagnostics Market Outlook, By Liver Transplant (2024-2032) ($MN)
21 Global Transplant Diagnostics Market Outlook, By Heart Transplant (2024-2032) ($MN)
22 Global Transplant Diagnostics Market Outlook, By Lung Transplant (2024-2032) ($MN)
23 Global Transplant Diagnostics Market Outlook, By Bone Marrow Transplant (2024-2032) ($MN)
24 Global Transplant Diagnostics Market Outlook, By Other Organ Transplants (2024-2032) ($MN)
25 Global Transplant Diagnostics Market Outlook, By Application (2024-2032) ($MN)
26 Global Transplant Diagnostics Market Outlook, By Human Leukocyte Antigen (HLA) Testing (2024-2032) ($MN)
27 Global Transplant Diagnostics Market Outlook, By Blood Profile Testing (2024-2032) ($MN)
28 Global Transplant Diagnostics Market Outlook, By Pathogen Detection (2024-2032) ($MN)
29 Global Transplant Diagnostics Market Outlook, By Crossmatching (2024-2032) ($MN)
30 Global Transplant Diagnostics Market Outlook, By Other Applications (2024-2032) ($MN)
31 Global Transplant Diagnostics Market Outlook, By End User (2024-2032) ($MN)
32 Global Transplant Diagnostics Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
33 Global Transplant Diagnostics Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
34 Global Transplant Diagnostics Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
35 Global Transplant Diagnostics Market Outlook, By Reference Labs (2024-2032) ($MN)
36 Global Transplant Diagnostics Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
